News|Articles|June 30, 2026
Merck Simplifies and Streamlines Method Development with In Silico Modeling (June 2026)
Author(s)ACD/Labs
Merck streamlines chromatographic method development using in silico modeling to improve efficiency, reduce experimentation, and accelerate decision-making.
Related Content
Trending on LCGC International
1
What FDA’s 2026 Draft Guidance Means for Antibody Drug Conjugates
2
What Determines a Best-in-Class Antibody Drug Conjugate
3
Important Analytical Measurements and Quality by Design for Bioconjugates
4
Framing the Evolving Bioconjugate Landscape
5